Archives

by in
Entry Author Date Location
Proteostasis, Astellas Join up on Genetic Disease Drugs 11/04/14 Boston
Try Then Buy? Sutro Deal Could Be Celgene’s Biggest Antibody Bet Yet 10/23/14 New York
New Atlas Startup Gets “Quartet” of Backers, $17M For Pain Drugs 10/23/14 Boston
East Coast Biotech Roundup: Berg, Forma/Celgene, Intarcia, & More 04/04/14 Boston
Forma Gets $225M More, And a Potential Buyout, From Celgene 04/01/14 Boston
Proteostasis, Biogen Team up on Protein Homeostasis Drugs 12/09/13 Boston
Celgene Emerges as Biotech’s Shrewdest, Nimblest Dealmaker 08/05/13 National
East Coast Life Sciences Roundup: Celgene, Dunsire, Forma, & More 07/12/13 Boston
Trusting Your Partners: A Chat With Celgene’s George Golumbeski 07/11/13 New York
Forma, CRT Deal Part of Broader Research Initiative 07/09/13 Boston
East Coast Life Sciences Roundup: Aveo, Forma, Regeneron, RainDance, & More 05/03/13 Boston
Forma Strikes $200M Deal With Celgene to Discover Cancer Drugs 04/29/13 Boston
Annovation, Agrivida, FashionPlaytes, & More Names from the Boston Deals Roundup 09/12/12 Boston
Forma Therapeutics Receives $10,000,000 New Financing 09/07/12 Boston
Biotech Wasn’t Immune to Job Loss in Great Recession, BIO Report Says 06/19/12 National
Genentech, Roche Find New Balance Three Years Post-Merger 05/29/12 San Francisco
Option to Buy: The New Face of Biotech Funding? 02/13/12 National
Join Kevin Starr, Corey Goodman, Carl Weissman & More in Seattle April 3 01/19/12 Seattle
LogMeIn, Safari, Forma, And More Behind the Boston-Area Deals News 01/11/12 Boston
Forma Reels In J&J With $700M Deal; 2nd Cancer Drug Discovery Partner in a Week 01/10/12 Boston
Alnylam, Aveo, Biogen, & More Boston Life Sciences Newsmakers 01/06/12 Boston
Forma Cuts $65M Deal With Boehringer Ingelheim to Discover Cancer Drugs 01/05/12 Boston
Editor’s Picks: Xconomy Boston’s Top 20ish Stories of 2011 12/28/11 Boston
Boston Xconomists and Area Innovators Gather for Special Xconomy Event: The Photos 10/13/11 Boston
Editor’s Picks: Xconomy Boston’s Top 20 Stories of the Second Quarter 07/01/11 Boston
Acetylon Adds $27M, Third Rock Leads Lotus Round, InfraReDx Gets $24M, & More Boston-Area Life Sciences News 07/01/11 Boston
Genentech Buys Rights to Forma Drug, Nimbus Gets $24M, Lilliputian Adds $11M, & More Boston-Area Deals News 06/29/11 Boston
Genentech Scoops Up Tumor-Starving Drug Program From Forma Therapeutics In Rare Deal 06/27/11 Boston
Epizyme Nabs Eisai Deal, Termeer Could Make $221.2M From Genzyme Buyout, Gates Funds Nimbus, & More Boston-Area Life Sciences News 03/11/11 Boston
Forma, After Building Cancer Drug Discovery Engine, Makes First Big Bet on Starving Tumors 03/10/11 Boston
Page 1 of 3 next page »